Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancerYang Zhang, Amit Verma, Xiaoyi Chen et al.|Journal of Hematology & Oncology|2022Cited by 35
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependencySarah Aminov, Amit Verma, Srabani Sahu et al.|Journal of Clinical Investigation|2024Cited by 20
Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancerYang Zhang, Amit Verma, Xiaoyi Chen et al.|Journal of Hematology & Oncology|2022Cited by 1
Abstract PO-045: Interleukin 1 receptor accessory protein (IL1RAP) in novel targetable pathway in pancreatic cancerYang Zhang, Amit Verma, Xiaoyi Chen et al.|Cancer Research|2020Cited by 0